Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysis

BACKGROUND: The objective of this study was to investigate whether baseline low-density lipoprotein cholesterol (LDL-C) levels influence total and cardiovascular mortality reduction associated with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor therapy. METHODS: In this meta-analysi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Lipidol
Asıl Yazarlar: Khan, Safi U., Riaz, Haris, Rahman, Hammad, Khan, Muhammad U., Khan, Muhammad Shahzeb, Alkhouli, Mohamad, Kaluski, Edo, Leucker, Thorsten M., Blaha, Michael J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294511/
https://ncbi.nlm.nih.gov/pubmed/31278046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2019.05.014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller